Single User License: $5500
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.
Report Includes
- 27 data tables and 50 additional tables
- An overview of the global market for nanomaterials in personalized medicine
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussions of the current and future market potential, and quantification of the market by product type and region
- Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
- Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
- Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
- Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
- Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
- Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
- Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma
Report Scope
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.
Report Synopsis
| Report Metrics | Details | ||||||
|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||
| Forecast period considered | 2023-2028 | ||||||
| Base year market size | $312.8 billion | ||||||
| Market size forecast | $592.0 billion | ||||||
| Growth rate | CAGR of 11.3% for the forecast period of 2023-2028 | ||||||
| Units considered | $ Billions | ||||||
| Segments covered | Product Type | ||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||
| Countries covered | U.S., Canada, Germany, France, U.K., Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific | ||||||
| Key Market Drivers |
|
||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global nanomaterials in personalized medicines market should reach $420.0 billion by 2025 from $253.8 billion in 2020 at a compound annual growth rate (CAGR) of 10.6% for the forecast period of 2020 to 2025.
Report Includes
- 43 tables
- A brief outlook of the global market for nanomaterials used in personalized medicine and pharmaceuticals within the industry
- Analyses of the global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025
- In-depth competitive market analysis of the key industry participants, their company share analysis, global rankings and product offerings
- Estimation of the actual market size and revenue forecasts for nanomaterials used in personalized medicine, and corresponding market share analysis by product type and region for each key market segment
- Discussion of market potential for nanomaterial applications in medicine and pharmaceuticals, industry value chain analysis, technology updates, and market growth drivers within the segment
- Insight into nanomaterial-based treatment methods for infections associated with medical devices and regulatory frameworks for personalized medicine
- Evaluation of global nanotechnology patents and significant allotment of patent data
- Company profiles of the leading industry players, including Novartis AG, Bristol-Myers Squibb Co., Beckman coulter, Merck & Co., Inc and Cytimmune Sciences
Report Highlights
The global theranostic nanomaterial market was estimated to total nearly $106 billion in 2011 and $112 billion in 2012. The market should total nearly $188 billion by 2017, and have a five-year compound annual growth rate (CAGR) of 10.8%.
This report provides:
- An overview of the global market for nanomaterials in medicine used for both therapy and diagnostics, or theranostics.
- Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Discussion of the advantages of nanoscale materials, such as in the fabrication of nano-machines that can deliver their cargo (a drug) to a precise location (for instance, the tumor tissue of a specific organ) so that healthy tissues are minimally affected, and in the fabrication of nano-drugs, diagnosis in vivo and therapeutic applications.
- Examination of the role of theranostics in oncology, immunodeficiencies, and cardiovascular and neuro disorders.
- Identification of the types of theranostic agents, such as gold-based, magnetic, polymeric, silica-based, carbon, composite, and lyposome nanomaterials.
Related Reports
PEGylated Proteins Market
The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Nanofibers
The global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028.
Global Nanotechnology Market
The global market for nanotechnology is estimated to increase from $68.0 billion in 2023 to reach $183.7 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% from 2023 through 2028.
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems
The global nanoparticles in biotechnology, drug development, and drug delivery systems market should reach $156.8 billion by 2028 from $102.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.8% for the forecast period of 2023 to 2028.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More